The gp130 ligand oncostatin M regulates tissue inhibitor of metalloproteinases-1 through ERK1/2 and p38 in human adult cardiac myocytes and in human adult cardiac fibroblasts: A possible role for the gp130/gp130 ligand system in the modulation of extracellular matrix degradation in the human heart

Theresa R. Weiss(Medical University of Vienna), Johann Wojta(Medical University of Vienna), Gerlinde Zorn(Wilhelminen Hospital), Gerald Maurer(European Society of Radiology), Stefan Pfaffenberger(Medical University of Vienna), Kurt Huber(Sigmund Freud Privatuniversität Wien), Heda Kvakan(Medical University of Vienna), Christoph Kaun(University of Vienna), Walter S. Speidl(University of Applied Sciences St Pölten)
Journal of Molecular and Cellular Cardiology
May 12, 2005
10.1016/j.yjmcc.2005.03.015
Cited by 48

Related Papers

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
|Circulation|2011|1.1k
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2011|877
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
|The Lancet|2018|793
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755